Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
LacTEST® is an unique oral diagnostic drug for Lactase deficiency (Lactose intolerance) based in a NCE that overcomes current deficiencies of existing diagnostic systems. LacTEST® has obtained marketing authorization in Spain and Germany through a More
CeaProve®: A Fast, Accurate and Easy Point-of-care Detection Screening of Pre-diabetes and Type 2 Diabetes More
Novel Diagnostic Method for Measuring Liver Function Reserve (LFR): Early Diagnostic of Hepatic Failure More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2007 - 87 pages - $1,999
Mar 2011 - 23 pages - $750
Feb 2012 - 1350 pages - $2,695
Mar 2011 - 23 pages - $750
Aug 2008 - 117 pages - $2,350
Jul 2010 - 6 pages - $500
Feb 2010 - 19 pages - $500
Apr 2010 - 510 pages - $2,695
Mar 2011 - 39 pages - $750
Apr 2011 - 951 pages - $4,995
Your selection
Browse By
- Industry sector
- Antibody-based diagnostics
- Biomarker-based diagnostics
- CAT
- Genetic diagnostics
- Imaging
- MRI
- Nuclear medicine
- Other
- Self-test systems
- Supplies
- Test systems
- Ultrasound
- X-ray
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us